Focus Universal Files to Sell 10.56M Shares of Common Stock
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 08 2025
0mins
Focus Universal files to sell 10.56M shares of common stock for holders
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FCUV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FCUV
About FCUV
Focus Universal Inc. is a provider of patented hardware and software design technologies for the Internet of Things (IoT) and fifth generation (5G). The Company has developed five disruptive patented technology platforms to solve the major problems facing hardware and software design and production within the industry. Perfecular, AVX, doing business as Smart AVX and Lusher jointly operate the SEC Financial Software segment, which involves the development, marketing, and production of its SEC Financial Reporting AI-Driven Automation Software package and also includes its universal smart instruments and devices in the hydroponic and controlled agriculture segments. AVX and Smart AVX (inclusive of the smart IoT Products sales under Smart AVX) run its LED and IoT Installation Services segment, which handles its IoT installation and management business, specializing in high performance and easy to use audio/video systems, home theaters, lighting control, automation, and integration.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%
- Reverse Stock Split Announcement: Aptevo Therapeutics has announced a 1-for-18 reverse stock split effective December 29, converting every 18 shares into one, which has led to a significant 38.4% drop in share price to $0.57, indicating a negative market reaction despite prior shareholder approval in July.
- Severe Market Reaction: Following the reverse stock split announcement, Aptevo's shares plummeted sharply during Friday's session, reflecting investor concerns about the company's future prospects, which could adversely affect its financing capabilities and market confidence.
- Shareholder Approval Context: The final ratio for the reverse split was approved by the board in mid-December, despite having received shareholder support at the July annual meeting, yet the market's response raises questions about the company's governance and strategic direction.
- Industry Impact: The sharp decline in Aptevo's stock price may affect its competitive position in the biopharmaceutical sector, particularly regarding financing and partnership opportunities, as investors may reassess its investment value.
Continue Reading
Spartan Capital Securities, LLC Acts as Lead Placement Agent for Focus Universal Inc.'s $10 Million Preferred Equity Raise
Investment Announcement: Spartan Capital Securities, LLC has successfully closed a $10 million preferred equity offering for Focus Universal Inc. to support its Universal Smart IoT platform and AI-driven SEC financial reporting software.
Funding Details: The offering, completed on October 23, 2025, included a $7 million round led by Spartan Capital, providing Focus with essential resources for commercialization.
Company Statements: John Lowry, CEO of Spartan Capital, expressed pride in supporting Focus Universal's innovative advancements in IoT and AI technologies.
Legal and Compliance Notes: The securities sold in this private placement were not registered under the Securities Act of 1933 and may only be sold in compliance with applicable registration requirements.
Continue Reading